ANRO vs. NATR, AMRN, ESPR, RANI, PEPG, NKTX, FBLG, PGEN, MREO, and HROW
Should you be buying Alto Neuroscience stock or one of its competitors? The main competitors of Alto Neuroscience include Nature's Sunshine Products (NATR), Amarin (AMRN), Esperion Therapeutics (ESPR), Rani Therapeutics (RANI), PepGen (PEPG), Nkarta (NKTX), FibroBiologics (FBLG), Precigen (PGEN), Mereo BioPharma Group (MREO), and Harrow Health (HROW). These companies are all part of the "pharmaceutical preparations" industry.
Nature's Sunshine Products (NASDAQ:NATR) and Alto Neuroscience (NYSE:ANRO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.
In the previous week, Nature's Sunshine Products had 4 more articles in the media than Alto Neuroscience. MarketBeat recorded 7 mentions for Nature's Sunshine Products and 3 mentions for Alto Neuroscience. Alto Neuroscience's average media sentiment score of 0.68 beat Nature's Sunshine Products' score of 0.20 indicating that Nature's Sunshine Products is being referred to more favorably in the media.
Nature's Sunshine Products presently has a consensus target price of $24.00, indicating a potential upside of 23.08%. Alto Neuroscience has a consensus target price of $32.33, indicating a potential upside of 128.02%. Given Nature's Sunshine Products' higher probable upside, analysts clearly believe Alto Neuroscience is more favorable than Nature's Sunshine Products.
Nature's Sunshine Products has higher revenue and earnings than Alto Neuroscience.
79.4% of Nature's Sunshine Products shares are held by institutional investors. 4.7% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Nature's Sunshine Products has a net margin of 3.39% compared to Nature's Sunshine Products' net margin of 0.00%. Alto Neuroscience's return on equity of 12.25% beat Nature's Sunshine Products' return on equity.
Nature's Sunshine Products received 155 more outperform votes than Alto Neuroscience when rated by MarketBeat users. However, 100.00% of users gave Alto Neuroscience an outperform vote while only 62.89% of users gave Nature's Sunshine Products an outperform vote.
Summary
Nature's Sunshine Products beats Alto Neuroscience on 10 of the 14 factors compared between the two stocks.
Get Alto Neuroscience News Delivered to You Automatically
Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ANRO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alto Neuroscience Competitors List
Related Companies and Tools
